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DOI: 10.1039/c2an16011kWe present a graphene oxide (GO) integrated disposable electrochemical sensor for the enhanced
detection of nucleic acids and the sensitive monitoring of the surface-confined interactions between the
anticancer drug mitomycin C (MC) and DNA. Interfacial interactions between immobilized calf
thymus double-stranded (dsDNA) and anticancer drug MC were investigated using differential pulse
voltammetry (DPV) and electrochemical impedance spectroscopy (EIS) techniques. Based on three
repetitive voltammetric measurements of 120 mg mL1 DNA immobilized on GO-modified electrodes,
the RSD % (n ¼ 3) was calculated as 10.47% and the detection limit (DL) for dsDNA was found to be
9.06 mg mL1. EIS studies revealed that the binding of the drug MC to dsDNA leads to a gradual
decrease of its negative charge. As a consequence of this interaction, the negative redox species were
allowed to approach the electrode, and thus increase the charge transfer kinetics. On the other hand,
DPV studies exploited the decrease of the guanine signal due to drug binding as the basis for specifically
probing the biointeraction process between MC and dsDNA.1. Introduction
In the last decade, there has been increasing attention on the
binding of small molecules to nucleic acids. Such studies have
a key importance for the rational design of more-efficient gene-
targeted agents.1 A variety of small molecules are known to
interact reversibly with dsDNA through one of the following
three modes: (i) electrostatic interactions with the negatively
charged nucleic sugar-phosphate structure; (ii) groove binding
interactions; or (iii) intercalations between the stacked base pairs
of dsDNA.2–5
Analysis of the interfacial biomolecular interaction between
DNA-targeted drugs and immobilized DNA probes has
a particular role in the rational design of novel DNA-binding
drugs and drug screening. The interactions of anticancer drugs
with nucleic acids have been studied by numerous physical and
biochemical techniques.6–9 Nuclear magnetic resonance, light
scattering studies, viscometry, electric linear and circularaEge University, Faculty of Pharmacy, Analytical Chemistry Dept.,
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This journal is ª The Royal Society of Chemistry 2012dichroism have been applied to provide insight into binding
modes, DNA affinity, and base pair selectivity of DNA-binding
drugs. However, these techniques mostly address the issues of the
binding mechanisms and structural analysis, such as DNA base
sequence selectivity, correlation of structure–activity relation-
ships, linkages between the geometry and thermodynamic
properties, and influences of substituent modifications on the
physical, chemical, and biological properties of the drug–DNA
complex. Nucleic acid layers combined with electrochemical
transducers have produced a new kind of affinity biosensor
capable of rapidly recognizing and monitoring DNA-binding
compounds.10–19 Electrochemical biosensors have been used
successfully for a number of applications including monitoring
DNA damage, studies of the interactions of DNA with various
genotoxic agents (carcinogens, toxins, mutagens, drugs, etc.),
and also for the detection of specific mutations in DNA
sequences. Thus, they potentially offer a faster and cheaper
alternative to traditional methods of measuring ligand–DNA
interactions.20–22
The recent advancements in the development of electro-
chemical sensors provide novel tools for monitoring biomolec-
ular recognition events at solid surfaces, or solution phases.10,16,18
Electrocatalytic oxidation of the antiviral drug acyclovir was
investigated by Heli et al.17 using a copper nanoparticles-modi-
fied carbon paste electrode in combination with cyclic voltam-
metry (CV) and chronoamperometry techniques. The
biomolecular interactions of platinum derivatives anticancer
drugs, cisdiamminedichloroplatinum(II) and oxaliplatin with calfAnalyst, 2012, 137, 2129–2135 | 2129
thymus dsDNA at the surfaces of a single-walled carbon nano-
tubes-modified graphite electrode were explored using DPV and
EIS techniques by Yapasan et al.18
Graphene has recently emerged as an interesting material in
numerous applications because of its unique electronic and
mechanical properties.23–27 Most of the graphene studies have
focused on its physical properties, such as its electronic proper-
ties, and these studies have demonstrated some applications in
gas28,29 and pH sensors.30 The first report concerning graphene
electrochemistry and electrocatalytic behaviour was published in
2008 by Shang et al.,31 who used as-grown arrays of vertically
aligned graphene nanosheets (GNSs) on silicon as dopamine
sensors. Because of their large specific surface area and the good
electron transfer ability graphene31,32 and graphene-modified
electrodes can enhance the sensitivity of solid bulk electrodes
compared to the unmodified ones.33,34
Since the discovery of graphene, a lot of interest has also been
focused on GO since it is the most inexpensive precursor for
obtaining large quantities of chemically converted graphene.
GO, an oxygenated graphene molecule, is formed by extensive
chemical oxidation of graphite to form graphite oxide, followed
by exfoliation to monolayer-thick sheets by techniques such as
sonication or slow-stirring in aqueous solution. Alwarappan
et al. used reduced graphene oxide (RGO) nanosheets for bio-
sensing applications in order to detect ascorbic acid, dopamine
and serotonin.33 In our earlier study, GO integrated on a single-
use graphite electrode was used for the sensitive and selective
detection of label-free DNA hybridization related to Hepatitis B
virus (HBV) sequences.35
MC is an anticancer antibiotic drug, which was isolated from
Streptomyces caespitosus and is used in clinical anticancer
chemotherapy, especially for gastrointestinal cancer. MC has
a cytotoxic character that damages normal human cells. Addi-
tionally, it was reported that MC can interact with nucleic acids
by binding to DNA bases, especially to GC pairs of dsDNA.36,37
Earlier studies were focused on monitoring the MC–DNA
interaction process by using different electrochemical trans-
ducers such as the hanging mercury drop electrode (HMDE),
carbon screen-printed electrodes (CSPEs) and carbon paste
electrodes (CPEs).38–41 Perez et al. investigated the electro-
chemical detection of DNA–MC adducts at the hanging mercury
drop electrode (HMDE) through their potential controlled
interaction at the electrode surface.41 Karadeniz et al. investi-
gated the interaction process in a microemulsion system carrying
the anticancer drug MC and DNA by using voltammetric
techniques.39
Through this work, we demonstrate for the first time the use of
the GO integrated electrode as a novel sensor platform for the
enhanced monitoring of the biointeraction process between the
anticancer drug MC and calf thymus dsDNA under optimum
experimental conditions. Firstly, disposable unmodified graphite
electrodes and GO-modified ones were tested for the individual
detection of drug MC and DNA in order to elucidate the signal
enhancement due to the presence of GO at the sensor surface.
The effect of MC concentration and DNA concentration has
been evaluated on the overall performance of the GO-modified
electrode. Then, the surface-confined interaction between MC
and DNA was monitored electrochemically by performing DPV
and EIS techniques.2130 | Analyst, 2012, 137, 2129–21352. Experimental
2.1. Apparatus
All electrochemical measurements were carried out using an
AUTOLAB - PGSTAT 302 system supplied with an FRA 2.0
module for impedance measurements and a GPES 4.9 software
package (Eco Chemie, The Netherlands). DPV and EIS
measurements were carried out. The three electrode system
consisted of a disposable pencil graphite electrode (PGE), an
Ag/AgCl/KCl reference electrode (BAS, Model RE-5B, W.
Lafayette, USA) and a platinum wire as the auxiliary electrode.
The EIS measurements were performed in a Faraday cage (Eco
Chemie, The Netherlands).2.2. Chemicals
The calf thymus dsDNA, polydAdT, and polydGdC were
purchased from Sigma-Aldrich. The stock solutions of dsDNA,
polydAdT and polydGdC were prepared in concentrations of
1 mg mL1 with Tris-EDTA (TE) buffer solution (10 mM Tris-
HCl, 1 mM EDTA, pH 8.00) and kept frozen (1000 mg L1).
More dilute solutions of dsDNA, polydAdT and polydGdC were
prepared with 0.50 M acetate buffer solution containing 20 mM
NaCl (ABS, pH 4.80).
MC was purchased from Sigma-Aldrich. The stock solution of
MC (1000 mg mL1) was prepared using ultrapure water. More
diluted solutions of MC varying from 5 to 120 mg mL1 were
prepared by using 20 mM Tris-HCl buffer solution (TBS, pH
7.00). Other all chemicals were of analytical reagent grade and
they were supplied from Sigma-Aldrich and Merck. All stock
solutions were prepared using ultrapure water.
Graphene oxide (GO). Graphene oxide (GO) was used for the
modification of the disposable electrode. GO nanosheets were
produced using the procedure presented in our earlier report35
that involved extensive sonification of graphite in strong acids.42
In more detail, 5 g of microcrystalline graphite was sonicated in
120 mL of a 3 : 1 mixture of 18 M H2SO4 and 17 M HNO3 over
2 h, with a Branson tip sonifier at a power level of 100 W, fol-
lowed by treatment in a sonication bath for 8 h. The dispersion
was allowed to stand at room temperature for 4 days; and the
colour of the dispersion turned to purple-brown. After repeated
washing by water, the oxide sheets were filtered through a 0.2 mm
PTFE membrane. Then, the product was allowed to dry under
vacuum overnight and the filtered material had a grayish
appearance.
The graphene oxide consisted of a few layers with a typical
thickness of 3–5 nm as observed by TEM.352.3. Procedure
Measurements included: (1) the immobilization of the nucleic
acid and its detection cycle, (2) MC immobilization and its
detection at unmodified and GO-modified disposable PGEs, and
(3) electrochemical investigation of the MC–DNA interaction at
GO-PGEs. All experiments were carried out at room
temperature.
The experimental scheme is presented in Scheme 1.This journal is ª The Royal Society of Chemistry 2012
Scheme 1 Experimental presentations for the modification of pretreated
PGEs respectively using GO and DNA, and voltammetric detection of
interaction between MC and DNA at the surface of GO-modified PGEs
based on the changes at the signals of MC and guanine.2.3.1. Preparation of GO solution and GO-modified PGEs.
The required amount of GO was suspended in the organic
solvent N,N-dimethylformamide (DMF), and this mixture was
then sonicated for 15 min at room temperature.
PGEs were pretreated by applying a potential of +1.40 V for
30 s in ABS.16,18 Each pretreated PGE was immersed into vials
containing 110 mL of 3000 mg mL1 GO solution for 1 h to form
a GO layer at the electrode surface. This easy surface modifica-
tion of disposable graphite electrodes using GO nanosheets was
performed by passive adsorption.35 Each of the GO-modified
PGEs was then allowed to dry for 30 min in an upward position.
2.3.2. Immobilization of dsDNA onto the surfaces of unmod-
ified PGE and GO-modified PGEs and DNA detection. The
unmodified/GO-modified PGEs were immersed into the vials
containing 110 mL of 120 mg mL1 of dsDNA solution in ABS for
an hour. The calf thymus DNA was immobilized onto these
surfaces by the formation of covalent amide linkages between the
carboxyl moieties on the GO surface and the amine group in
guanine bases of DNA without any further activation step by
using chemical agents N-(3-dimethylamino)propyl-N0-ethyl-
carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide
(NHS).35 Each of the electrodes was then rinsed with ABS for
10 s before voltammetric transduction as given below.
2.3.3. MC immobilization onto the surfaces of unmodified
PGE and GO-modified PGEs. The unmodified/GO-modifiedThis journal is ª The Royal Society of Chemistry 2012PGEs were immersed into the vials containing 110 mL of 80 mg
mL1 of MC in TBS for 7.5 min. MC was immobilized on GO
through the formation of covalent linkages between the carboxyl
moieties of GO and amine groups in MC. Each of the electrodes
was then rinsed with TBS for 10 s to remove nonspecific bound
MC, before voltammetric transduction as given below.
2.3.4. Interaction of MC with dsDNA at the surface of
GO-modified electrode. For preparation of GO-modified elec-
trodes, the same procedure was followed as given above. The
GO-modified PGEs were immersed into the vials containing
110 mL of 120 mg mL1 of dsDNA solution in ABS for an hour.
Each of the electrodes was then rinsed with ABS for 10 s before
interaction with MC. DNA-immobilized electrodes were
immersed into the vials containing 110 mL of 80 mg mL1 MC and
allowed to interact for various predetermined durations. Then,
each electrode was rinsed with TBS for 10 s before voltammetric
transduction.
2.4. Voltammetric transduction
After DNA/MC immobilization onto the surfaces of the
unmodified PGEs/GO-modified PGEs, DPV measurements
were performed in ABS to measure the oxidation signals of
MC/guanine by scanning from +0.20 to +1.40 V at a pulse
amplitude of 50 mV and a scan rate of 50 mV s1.
The same voltammetric transduction was performed to
monitor the changes in the signals of MC and/or guanine before/
after the interaction process.
2.5. Impedance measurements
The surfaces of unmodified PGEs and GO-modified PGEs were
characterized via the EIS technique according to the procedure
given below. In order to monitor the MC interaction with
dsDNA immobilized onto the GO-modified PGE, EIS
measurements were also performed at the same conditions.
EIS measurements were performed in the presence of a 2.5 mM
K3[Fe(CN)6]/K4[Fe(CN)6] (1 : 1) mixture, as a redox probe
prepared in 0.1 M KCl. The impedance was measured in the
frequency range from 105 Hz to 101 Hz in an open-circuit
potential value of +0.23 V, versus Ag/AgCl with a sinusoidal
signal of 10 mV. The respective semicircle diameter corresponds
to the charge-transfer resistance, Rct, the value of which was
calculated using the fitting program of AUTOLAB 302 (FRA,
version 4.9 Eco Chemie, The Netherlands).
Results and discussion
X-Ray photoelectron spectroscopy (XPS) was employed in our
study to investigate the oxidation level of GO. The quantification
of the data revealed an oxidation content of 19.08 at% and
a C : O ratio of 4.24. Fig. 1 shows the C1s peak which is
deconvoluted into five components located at 284.49, 285.67,
286.78, 287.90 and 289.00 eV corresponding to sp2 (C]C),
hydroxyl (C–OH), epoxide (C–O–C), carbonyl (>C]O) and
carboxyl (COOH or HO–C]O) groups, respectively. A (p–p*)
shake up satellite peak can also be seen at 290.7 eV.
Firstly, the role of GO was elucidated by comparing the
response from 50 mg mL1 calf thymus dsDNA immobilized onAnalyst, 2012, 137, 2129–2135 | 2131
Fig. 1 XPS spectrum of the graphene oxide (GO).
Fig. 3 Calibration plot presenting the changes of guanine oxidation
signal measured in the presence of different concentrations of dsDNA
varying from 20 to 120 mg mL1 by using GO-PGEs.
PGE with and without GO coating. The enhanced guanine
oxidation signal was observed at +1.01 V by the GO-modified
electrode compared to the unmodified one (Fig. 2). It was found
that the response increased approximately by 34.4% with the
presence of GO. This increase of guanine signal could indicate
that GO enhances the surface area for the binding of nucleic
acids.
After DNA immobilization onto the surface of the GO-
modified PGEs, the changes in guanine signals were also inves-
tigated at various dsDNA concentrations as shown in Fig. 3. A
sharp rise in the response was obtained up to 120 mg mL1, with
the response leveling off at higher DNA concentrations. Thus,
120 mg mL1 was chosen as the optimumDNA concentration for
further studies, indicating the highest DNA coverage at the
surfaces of the GO-modified PGEs. Based on three repetitive
voltammetric measurements using 120 mg mL1 DNA immobi-
lized onto GO-modified electrodes, the RSD (n ¼ 3) was calcu-
lated as 10.47%.
A commonly used definition of the DL in the literature of
literature of analytical chemistry is that the DL is the analyte
concentration giving a signal equal to the blank signal, plus three
standard deviations of the blank, i.e.
y ¼ yB + 32B (1)
The DL was calculated with the aid of the section of the cali-
bration plot close to the origin (show as the inset in Fig. 3)Fig. 2 DPVs representing the guanine oxidation signals observed by
using an unmodified electrode (a) and the GO-modified electrode (b) in
the presence of calf thymus 50 mg mL1 dsDNA immobilized during an
hour onto the surfaces of electrodes, and (c) the control experiment
performed in the absence of DNA by using 3000 mg mL1 GO-modified
electrodes.
2132 | Analyst, 2012, 137, 2129–2135utilizing the regression equation and eqn (1) above.43 Based on
this procedure the DL for dsDNA was calculated as 9.06 mg
mL1 with a regression equation: y ¼ 0.046x + 1.465 and
a regression coefficient (R2) of 0.9954.
In our study, these disposable GO-modified PGEs were used
for electrochemical monitoring of anticancer drug–DNA inter-
actions. Under this scope, the anticancer drug MC was chosen as
the target compound; this has cytotoxic character, since it can
cause damage to normal human cells.36,37 It is known that MC
can interact with nucleic acids by binding to the GC pairs of
dsDNA.44–48
Before monitoring the surface-confined interaction process,
the electrochemical behaviour of MC was investigated at both
the unmodified electrode and GO-modified electrode. After the
accumulation of 20 mg mL1 MC onto the surfaces of these
electrodes, the MC oxidation signals were monitored at +0.86 V
by using DPV (shown in Fig. 4). It was shown that an increase of
21.4% was obtained for the MC signal after the GO modification
onto the electrode surface. Due to the high density of the
carboxyl moieties at the surface of the GO-modified PGE, more
MC molecules could accumulate on the surface by the formation
of covalent linkage between the carboxyl moieties and the amine
groups in MC. It can be concluded that the GO could improve
greatly the immobilization capacity and efficiency of the graphiteFig. 4 (A) DPVs and (B) histograms representing the MC oxidation
signals observed by using the unmodified electrode and GO-modified
electrode in the absence of MC (a), in the presence of 20 mg mL1 MC
immobilized for a period of 7.5 min onto the surface of the unmodified
electrodes (b), and 3000 mg mL1 GO-modified electrodes (c).
This journal is ª The Royal Society of Chemistry 2012
surfaces.33–35 In addition, the reproducibility of the GO-modified
electrode was found to be much better (RSD % (n ¼ 3); 5.24%)
than that of the unmodified one (RSD % (n ¼ 3); 23.90%).
In order to find the optimum MC concentration on the GO-
modified PGE, the changes of MC oxidation signal were moni-
tored for a range of MC concentrations varying from 5 to 120 mg
mL1. A sharp increase in the MC signal was obtained for
concentrations up to 80 mg mL1 (Fig. S1†), and then the
response leveled off till 120 mg mL1 of MC (not shown). Thus,
80 mg mL1 was chosen as the optimum MC concentration for
our further study. From the resulting calibration plot of MC
(shown inset in Fig. S1†), the detection limit (DL) was calculated
as 4.72 mg mL1 according to procedure described by Miller and
Miller.43
Fig. 5 shows representative voltammograms andhistograms for
MC and guanine signals observed before and after the surface-
confined interaction process at GO-modified disposable elec-
trodes exposed to 80 mg mL1 MC and 120 mg mL1 of dsDNA
solutions for different interaction times of 7.5min (Fig. 5AandB),
15 min (Fig. 5C and D) and 30 min (Fig. 5E and F). The DPV
measurements show the oxidation signals of MC and guanine,
measured at +0.86 V and +1.01 V respectively. In the case of the
7.5 min interaction time, a gradual decrease of 31.3% and 94.3%
was obtained for MC and guanine signals respectively (shown inFig. 5 (A), (C), (E) DPVs and (B), (D), (F) histograms representing MC an
80 mg mL1 MCwith 120 mg mL1 dsDNA using GO-PGEs. (A) and (B) for 7.5
for 30 min interaction time; the oxidation signal of MC: (a) before interaction
(b) before interaction, (b0) after interaction of MC with dsDNA.
This journal is ª The Royal Society of Chemistry 2012Fig. 5AandB, a to a0 andb tob0). For aprolonged interaction time
of 30 min, the decrease of the signals was found as 58.1% forMC,
and 97.2% for guanine (shown inFig. 5E andF, a to a0 and b to b0).
A similar significant decrease of the guanine signal was explained
in earlier reports38–40,44 by the shielding of oxidizable groups of
electroactive DNA bases following the surface-confined interac-
tion of the drug within dsDNA.
Before and after the interaction process of MC with the pol-
ydAdT-modified electrode, or polydGdC-modified electrode, the
changes of the MC oxidation signal were also monitored in order
to prove the preferential interaction of MC for the G–C sites
compared to the A–T sites of the DNA (shown in Fig. S2†).
Similar to the results shown in Fig. 5A, a to a0, a 37.5%
decrease of the MC signal was also recorded for the MC–pol-
ydGdC interaction time of 7.5 min (shown in Fig. S2a to c†). By
contrast, there was only a 1.4% decrease forMC signal in the case
of the MC–polydAdT interaction (shown in Fig. S2a and b†).
Weaver and Tomasz48 reported that the 2-amino group of the
guanine residues in synthetic polyribonucleotides are the major
covalent binding sites with the antibiotic MC. Later, Paz et al.49
reported that DNA damage is generated from mono- and bi-
functional alkylation of the guanine residues by MC leading to
MC–guanine monoadducts and MC–guanine bisadducts; the
latter constitute DNA interstrand and intrastrand cross-links,d guanine oxidation signals observed before and after the interaction of
min interaction time; (C) and (D) for 15 min interaction time; (E) and (F)
, (a0) after interaction with dsDNA; and the oxidation signal of guanine:
Analyst, 2012, 137, 2129–2135 | 2133
Fig. 6 Nyquist diagrams recorded at the GO-modified electrode before
and after interaction of 80 mg mL1 MC with 120 mg mL1 dsDNA at
different interaction times of 7.5 and 30 min. Inset is the equivalent circuit
model used to fit the impedance data, the parameters of which are: RS is
the solution resistance; the constant phase element Cd is related to the
space charge capacitance at the DNA/electrolyte interface; Rct represents
the charge transfer resistance at the DNA/electrolyte interface; the
constant phase elementW is theWarburg impedance due to mass transfer
to the electrode surface.which are formed specifically at CpG and GpG base pairs of
dsDNA. In agreement with earlier studies performed using
different electrochemical transducers (CSPE, CPE and
HMDE38–40,44), similar damage is expected to occur at the
oxidizable groups of the guanine base due to the biointeraction
process between MC and dsDNA on our electrodes.
In our study, the guanine peak magnitude was also used as the
transduction signal for recognizing the DNA interacting agent,
MC. As a result ofMC interaction with dsDNA, a decrease in the
guanine signal was obtained (Fig. 5). DNA modifications were
estimated based on the value of the percentage of guanine peak
height change (S%),50 which is the ratio of the guanine peak
height after the interaction (Ss), and the guanine peak height
before the interaction (Sb):
S% ¼ (Ss/Sb)  100
Thus, the DPV signal of the sensor in the absence of the analyte
served as a ‘blank’, or 100%. Conventionally, if a sample had an
S > 85% it was considered not to be toxic, whereas if it had an S%
between 50 and 85 was considered moderately toxic and if it had
an S < 50% was considered toxic.50 Using the equation given
above, the values of S% were calculated for 7.5, 15 and 30 min,
and were found to be 5.7, 3.3, and 2.8% respectively. Based on
these calculated S% values, MC can be considered as a toxic
chemical.
In accordance with the reference method of Ozkan et al.,38 the
partition coefficient of MC on the surface of the GO-modified
electrode was estimated from the results presented in Fig. 5 by
the following equation:
Partition coefficient ¼ MCbound/MCfree ¼ |(ibound  ifree)/ifree|
where ifree is the oxidation peak current of MC obtained before
and ibound is the oxidation peak current of MC obtained after2134 | Analyst, 2012, 137, 2129–2135interaction with dsDNA. In agreement with this work,38 the
partition coefficient for 80 mg mL1 MC was found to be 0.31 and
0.58 for 7.5 and 30 min interaction times, respectively.
Based on three repetitive voltammetric measurements
employing solutions of 80 mg mL1 MC and 120 mg mL1 dsDNA
the mean response of the MC and guanine oxidation signals were
calculated as 5850 824.72 nA and 188 52 nA respectively and
the detection limit (S/N ¼ 3) was estimated as 1.39 mg mL1
which is comparable to the values reported in earlier works.41,44,51
With respect to the electrode modification approach, a simpler
and faster modification step was used herein for the development
of disposable GO-modified electrodes by following passive
adsorption. In addition, a smaller amount of nucleic acid
was employed compared to the electrodes modified with
poly(vinylferrocenium) (PVF+),40 or single-walled carbon nano-
tube (SWCNT)/PVF+,52 prepared electrochemically by potential-
controlled coulometry technique.
EIS was used to probe the various steps on the construction of
the sensor. Following GO modification, the average Rct value
was calculated as 178U (shown in Fig. 6), which is larger than the
one obtained by the unmodified one (not shown). The change of
the Rct value after modification was strong proof that GO had
been immobilized on the electrode surface. A further increase of
the Rct values was obtained after dsDNA immobilization onto
the surface of the GO-modified electrode as a result of the
enhanced resistance to the charge-transfer at the electrode
surface. The negatively charged phosphate backbone of dsDNA
prevented the redox couple, [Fe(CN)6]
3/4, from reaching the
electrode surface, leading to an almost 3.5 times larger Rct value
(Fig. 6). The surface-confined interaction of the anticancer drug
MC with dsDNA at different interaction times, e.g. 7.5 and 30
min, led to a decrease in the Rct value by 7.1% and 20.5%
respectively. The interaction of MCwith the double helix form of
DNA at the electrode surface should decrease the negative
charge present on the electrode surface, thus reducing the resis-
tance the charge transfer. Consequently, the EIS results com-
plemented successfully the voltammetric results for monitoring
this biomolecular recognition process.4. Conclusion
Through this work we report for the first time that GO-modified
PGEs can yield a rapid and sensitive route for the detection of
nucleic acids (dsDNA) and drugs, using as model system the
anticancer drug MC. Easy surface modification of PGE with GO
was performed herein using smaller amounts of nucleic acids to
develop single-use GO-modified DNA sensors compared to the
earlier advanced DNA sensors modified using PVF+,40 or
SWCNT/PVF+.52
A signal enhancement of 21.4% and 34.4% was obtained for
MC and guanine respectively by using GO-modified disposable
electrodes in comparison with the unmodified ones due to the
fact that the GO provides a higher surface area at the electrode
surface for the binding of drug, or nucleic acids.
Additionally, the GO-based sensor technology was demon-
strated for the sensitive electrochemical detection of the biomo-
lecular interaction process between MC and dsDNA. The high
decreases in both signals of MC and guanine were recorded as
31.3–58.1% for MC, and 94.3–97.2% for guanine after theThis journal is ª The Royal Society of Chemistry 2012
interaction process at the surface of the GO-modified electrode in
different interaction times of 7.5 and 30 min.
As a conclusion, single-use GO-modified electrodes developed
for monitoring biorecognition processes have presented many
advantages: being easy to use, cost-effective, enabling rapid
detection with good repeatability in comparison to the conven-
tional electrodes, e.g., CPE, glassy carbon electrode, CSPE,
HMDE, gold electrode and advanced ones modified using
conductive polymers and carbon nanotubes.Acknowledgements
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